Viewing Study NCT05051904


Ignite Creation Date: 2025-12-24 @ 9:08 PM
Ignite Modification Date: 2026-01-26 @ 8:39 PM
Study NCT ID: NCT05051904
Status: COMPLETED
Last Update Posted: 2024-03-07
First Post: 2021-09-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Based on Japanese Medical Records That Looks at Bleeding Events in People With Atrial Fibrillation and Coronary Artery Disease Who Start Taking Either Dabigatran, Rivaroxaban, or Warfarin
Sponsor: Boehringer Ingelheim
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Coronary Artery Disease View
None Atrial Fibrillation View
Keywords: